ACA

NEUTRALM&A

Arcosa, Inc.

2026-09-14

Price

$145.15

+0.10%

This is the 2026-09-14 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score9.0Priority

Signals6/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.2xvs 20d avg

Analysis

Arcosa's price action is entirely anchored by its pending $150 per share all-cash acquisition by CRH, which was formally approved by stockholders on September 4, 2026. The extreme low volatility signals like the Bollinger Squeeze and Quiet Storm perfectly reflect a stock locked in a tight merger arbitrage spread rather than natural price discovery. Furthermore, the current RISK_ON macro regime and exceptionally tight credit spreads provide high conviction that the deal's financing is secure, allowing institutional investors to comfortably absorb shares just below the takeout price as they await the Q1 2027 close.

Fired Signals

ALPHA MALEQUIET STORMGOLDEN CROSSBOLLINGER SQUEEZEMARKET LEADERPERFECT STACKDISTRIBUTION

Key Takeaways

Actionable Thesis: ACA is a pure merger arbitrage play, offering a defined spread up to the $150 all-cash takeout price following recent shareholder approval.
Key Risk: Unexpected regulatory or antitrust hurdles that could delay or block the CRH acquisition before its expected Q1 2027 close.
What to Watch: Keep an eye on the $144.90 support level as a proxy for institutional deal confidence, alongside any regulatory filings related to the merger.

← Back to 2026-09-14 View Full ACA History →Yahoo Finance &nearr;